⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20836934 | 0.81 | — | — | |
| SCHEMBL10280898 | 0.81 | — | — | |
| SCHEMBL23812019 | 0.74 | ESR2 (0.31) | — | |
| SCHEMBL9141961 | 0.72 | TSHR (0.44) | — | |
| SCHEMBL22053497 | 0.69 | ESR2 (0.34) | — | |
| SCHEMBL5528498 | 0.69 | — | — | |
| SCHEMBL2007584 | 0.69 | — | — | |
| Ethylene SCHEMBL2933706 | 0.69 | ESR2 (0.38) | — | |
| SCHEMBL8611 | 0.68 | — | — | |
| SCHEMBL14274542 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120077126-A | Oxidation of steroids | 牛津大学创新有限公司 | 2025-05-30 | — | — | CN | claimed |
| WO-2026103877-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 中生复诺健生物科技(上海)有限公司 | 2026-05-21 | — | — | WO | disclosed |
| US-20260098049-A1 | KRAS MODULATING COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-04-09 | — | — | US | disclosed |
| CN-120077126-A | Oxidation of steroids | 牛津大学创新有限公司 | 2025-05-30 | — | — | CN | disclosed |
| WO-2019006548-A1 | FLUORINATED 2,4-DIAMINOPYRIMIDINE COMPOUNDS AS MER TYROSINE KINASE (MERTK) INHIBITORS AND USES THEREOF | TRILLIUM THERAPEUTICS INC. (CA) | 2019-01-10 | — | — | WO | disclosed |
| US-20180117156-A1 | 1-DEOXY ANALOGS OF VITAMIN D-RELATED COMPOUNDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-05-03 | — | — | US | disclosed |
| EP-2975044-B1 | SYMMETRICAL HYPERBRANCHED SILICONE-MODIFIED POLYMERIZABLE COMPOUND AND PREPARATION METHOD MODULARIZING SAME | SHINETSU CHEMICAL CO (JP) | 2017-07-12 | — | — | EP | disclosed |
| EP-2778169-B1 | Symmetric hyperbranched silicone-modified polymerizable compound and modularized manufacturing method thereof | SHINETSU CHEMICAL CO (JP) | 2016-12-07 | — | — | EP | disclosed |
| US-9428527-B2 | Symmetric hyperbranched type silicone-modified polymerizable compound, and its modularized preparation method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-30 | — | — | US | disclosed |
| US-20160039848-A1 | SYMMETRIC HYPERBRANCHED TYPE SILICONE-MODIFIED POLYMERIZABLE COMPOUND, AND ITS MODULARIZED PREPARATION METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-02-11 | — | — | US | disclosed |
| EP-1981877-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | Astellas Pharma Inc. (JP) | 2008-10-22 | — | — | EP | disclosed |
| WO-2008063714-A1 | METABOLICALLY-STABILIZED INHIBITORS OF FATTY ACID AMIDE HYDROLASE | N.V. ORGANON (NL) | 2008-05-29 | — | — | WO | disclosed |
| US-20080119549-A1 | METABOLICALLY-STABILIZED INHIBITORS OF FATTY ACID AMIDE HYDROLASE | N.V. ORGANON (NL) | 2008-05-22 | — | — | US | disclosed |
| US-20080119549-A1 | METABOLICALLY-STABILIZED INHIBITORS OF FATTY ACID AMIDE HYDROLASE | N.V. ORGANON (NL) | 2008-05-22 | — | — | US | disclosed |
| WO-2008043031-A1 | 6-SUBSTITUTED 2-(BENZIMIDAZOLYL)PURINE AND PURINONE DERIVATIVES FOR IMMUNOSUPPRESSION | PHARMACOPEIA, INC. (US) | 2008-04-10 | — | — | WO | disclosed |
| US-20080070936-A1 | Compounds specific to adenosine A1 receptors and uses thereof | OSI PHARMACEUTICALS, INC. | 2008-03-20 | — | — | US | disclosed |
| WO-2007115306-A2 | COMPOUNDS FOR DISEASES AND DISORDERS | MYRIAD GENETICS, INC. (US) | 2007-10-11 | — | — | WO | disclosed |
| WO-2007091703-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | ASTELLAS PHARMA INC. (JP) | 2007-08-16 | — | — | WO | disclosed |
| US-4816452-A | ANTIBIOTICS | BEECHAM GROUP P.L.C. (GB) | 1989-03-28 | — | — | US | disclosed |
| EP-0210815-A2 | 6-Beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use | BEECHAM GROUP PLC (GB) | 1987-02-04 | — | — | EP | disclosed |